Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis

[1]  D. Baker,et al.  Cellular senescence in ageing: from mechanisms to therapeutic opportunities , 2020, Nature Reviews Molecular Cell Biology.

[2]  S. Giannouli,et al.  Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus , 2019, Annals of the rheumatic diseases.

[3]  E. Passegué,et al.  TNF-α Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration. , 2019, Cell stem cell.

[4]  L. Joosten,et al.  Therapeutic targeting of trained immunity , 2019, Nature Reviews Drug Discovery.

[5]  S. Stewart,et al.  Unmasking senescence: context-dependent effects of SASP in cancer , 2019, Nature Reviews Cancer.

[6]  Ahmet Dogan,et al.  Efficacy of MEK Inhibition in Patients with Histiocytic Neoplasms , 2019, Nature.

[7]  Soyoung Lee,et al.  The dynamic nature of senescence in cancer , 2019, Nature Cell Biology.

[8]  M. Merad,et al.  Langerhans‐Cell Histiocytosis , 2018, New England Journal of Medicine.

[9]  A. Annoni,et al.  Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy , 2017, EMBO molecular medicine.

[10]  D. Baker,et al.  Senescent cells: an emerging target for diseases of ageing , 2017, Nature Reviews Drug Discovery.

[11]  N. McGovern,et al.  Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. , 2017, Blood.

[12]  L. Biasco,et al.  Multiparametric Whole Blood Dissection: A one‐shot comprehensive picture of the human hematopoietic system , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[13]  M. Nolte,et al.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output , 2016, Front. Immunol..

[14]  Luca Tiano,et al.  Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells , 2016, Oncotarget.

[15]  M. Grever,et al.  Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. , 2015, The New England journal of medicine.

[16]  V. Bigley,et al.  Cell(s) of Origin of Langerhans Cell Histiocytosis. , 2015, Hematology/oncology clinics of North America.

[17]  M. Merad,et al.  BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups , 2015, The Journal of experimental medicine.

[18]  A. Schambach,et al.  A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage , 2014 .

[19]  O. Abdel-Wahab,et al.  BRAF-mutant hematopoietic malignancies , 2014, Oncotarget.

[20]  P. A. Pérez-Mancera,et al.  Inside and out: the activities of senescence in cancer , 2014, Nature Reviews Cancer.

[21]  G. Cavalli,et al.  Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease , 2014, Front. Immunol..

[22]  V. Poletti,et al.  Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis , 2014, Leukemia and Lymphoma.

[23]  C. von Kalle,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy , 2013, Science.

[24]  C. Doglioni,et al.  Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  D. Fremont,et al.  Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells. , 2012, Blood.

[26]  N. Korman,et al.  Langerhans Cell Histiocytosis , 2012, Journal of cutaneous medicine and surgery.

[27]  Debashis Sahoo,et al.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age , 2011, Proceedings of the National Academy of Sciences.

[28]  R. Sen,et al.  Faculty Opinions recommendation of Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. , 2010 .

[29]  Judith Campisi,et al.  Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network , 2009, Proceedings of the National Academy of Sciences.

[30]  Aaron Bensimon,et al.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.

[31]  C. Pritchard,et al.  Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. , 2005, Cancer research.

[32]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[33]  Goberdhan P Dimri,et al.  Mechanisms of cellular senescence in human and mouse cells , 2004, Biogerontology.